{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioTech Nation ... with Dr. Moira Gunn","title":"One Company, Two Different Drugs - It's All About Glucose - Too Much and Too Little! Nevan Charles Elam, Founder & CEO, Rezolute","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a7cfe86d\"></iframe>","width":"100%","height":180,"duration":1132,"description":"Glucose is essential for life. And the insulin we produce is designed to leave just the right of amount in our bodies for healthy functioning. Thus, when we underproduce insulin - or we overproduce it - the results can be devastating. Nevan Charles Elam, Founder and CEO of Rezolute, tells us about their work to treat the “diabetic eye condition”, DME, and a pediatric condition called Congenital hyperinsulinism. ","thumbnail_url":"https://img.transistorcdn.com/2O-bvNE3apnAmlMA6TtfHcDLDnv2fCS4nzWuofCE46M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzMxMTgyLzE2NTM3/NjI1NzctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}